Literature DB >> 15297232

[Clinical value of crystalluria study].

M Daudon1, P Jungers, B Lacour.   

Abstract

Crystalluria is a marker of urine supersaturation present in both normal and pathological conditions. Indeed, nature and characteristics of the spontaneous crystalluria are of clinical interest for detecting and following biological disorders involved in renal diseases. Method. Crystalluria examination should preferably be performed on first morning urine or fresh fasting voiding samples by polarised microscopy in a Malassez cell. Urine samples must be stored at 37 degrees C or at room temperature and examined within two hours following voiding. Results and discussion. Crystalluria should be interpreted according to various criteria: 1) chemical nature of crystals for abnormal crystals such as struvite, ammonium urate, cystine, dihydroxyadenine, xanthine or drugs; 2) crystalline phase of common chemical species as calcium oxalates, calcium phosphates and uric acids; 3) crystal morphology (calcium oxalates); 4) crystal size (calcium oxalates); 5) crystal abundance (calcium oxalates, calcium phosphates, uric acids, cystine); 6) crystal aggregation (calcium oxalates); 7) frequency of crystalluria assessed on serial first morning urine samples, a very useful tool for long-term surveillance of patients. Within calcium oxalate crystalluria, presence of whewellite is a marker of elevated oxalate concentration (urine oxalate > 0.3 mmol/L); a crystal number > 200/mm 3 is highly suggestive of heavy hyperoxaluria of genetic or absorptive origin. Predominant weddellite crystalluria is most often indicative of an excessive urine calcium concentration (> 3.8 mmol/L); a dodecahedric aspect of the crystals is a marker for heavy hypercalciuria (> 6 mmol/L) while an increased crystal size (>or= 35 microm) is indicative of simultaneous hypercalciuria and hyperoxaluria. Calculation of the global crystal volume, especially when applied to calcium oxalates or cystine, is a clinically useful tool for the monitoring of patients suffering from primary hyperoxaluria or cystinuria. Lastly, presence of crystalluria in more than 50% of serial first voided morning urine samples is in our experience the most reliable biological marker for detecting the risk of stone recurrence in lithiasic patients. Conclusion. Crystalluria examination is an essential laboratory test for detecting and following pathological conditions, which may induce renal stone disease or alter kidney function due to urine crystals. Copyright John Libbey Eurotext 2003.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297232

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  9 in total

1.  Stone symptoms and urinary deposits.

Authors:  Y M Fazil Marickar; Abiya Salim; Adarsh Vijay
Journal:  Urol Res       Date:  2009-11-04

2.  Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats.

Authors:  Jun Mi; Jianmin Duan; Jun Zhang; Jianzhong Lu; Hanzhang Wang; Zhiping Wang
Journal:  Urol Res       Date:  2011-08-06

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

4.  Photmicrography of urinary deposits in stone clinic.

Authors:  Y M Fazil Marickar; Abiya Salim
Journal:  Urol Res       Date:  2009-10-16

5.  Heavy elements in urinary stones.

Authors:  D Bazin; P Chevallier; G Matzen; P Jungers; M Daudon
Journal:  Urol Res       Date:  2007-05-10

6.  Crystalluria in HIV/AIDS patients on highly active anti-retroviral therapy in the Kumasi metropolis; a cross sectional study.

Authors:  Richard K D Ephraim; Ruth C Brenyah; Richmond Osei; Bright D Bossipe; Prince Adoba; Derick N M Osakunor; Hope Agbodzakey
Journal:  Niger Med J       Date:  2014-11

Review 7.  Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.

Authors:  R Geraghty; K Wood; J A Sayer
Journal:  Urolithiasis       Date:  2020-07-27       Impact factor: 3.436

8.  Neural Network Analysis of Crystalluria Content to Predict Urinary Stone Type.

Authors:  Raed M Almannie; Abdullah K Alsufyani; Abdullah U Alturki; Mana Almuhaideb; Saleh Binsaleh; Abdulaziz M Althunayan; Mohammed A Alomar; Khalid M Albarraq; Fahad A Alyami
Journal:  Res Rep Urol       Date:  2021-12-29

Review 9.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.